{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Codexis, Inc."},"Symbol":{"label":"Symbol","value":"CDXS"},"Address":{"label":"Address","value":"200 PENOBSCOT DRIVE, REDWOOD, California, 94063, United States"},"Phone":{"label":"Phone","value":"+1 650 421-8100"},"Industry":{"label":"Industry","value":"Major Chemicals"},"Sector":{"label":"Sector","value":"Industrials"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products. The firm's products and services include Screening and Evolution services, Enzymes, Screening Kits. It also develops protein engineering and biocatalyst platforms such as Codeevolver, Ketoreductases, Transminases, Imine reductases, etc. The company operates in two business segments namely Performance Enzymes and Novel Biotherapeutics. It generates maximum revenue from the Performance Enzymes segment."},"CompanyUrl":{"label":"Company Url","value":"https://www.codexis.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Kevin Norrett","title":"Chief Operating Officer"},{"name":"Stefan Lutz","title":"Senior Vice President-Research"},{"name":"Stephen George Dilly","title":"Chairman, President & Chief Executive Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}